Head of Research


Laure has a Master’s Degree in Human Resources from IGS Paris, a Postgraduate Diploma in German from the University of Strasbourg and is also qualified as an accountant (DECF).
Prior to joining the Virdis Group Laure worked in human resources and training within Sanofi and GlaxoSmithKline in France.  She moved to the UK in 2008 where she leads the Virdis Group research team.
Laure is an experienced and active executive search consultant for several of our long-established international pharmaceutical  and medical device clients.





Matt read Music Composition and Professional Practice at Coventry University, before completing a post graduate degree in Education from the University of Birmingham.

Matt has particular expertise with commercial and business development roles, especially within emerging and start-up businesses.

In addition, he has established a wide network to support statistical and scientific assignments across Europe and North America.

He has significant experience of working in recruitment and executive search for the UK government, as well as within the pharmaceutical and biotech industry. Matt joined the Virdis Group in 2012.





Olga is multilingual, originally from Colombia, and with an academic background in Clinical & Health Psychology from the University of Mainz, in Germany.

She has experience in academic recruitment and media analysis prior to joining the Virdis Group research and consultancy team in 2012.

Olga has particular expertise in medical affairs, market access and animal health roles.




John brings over 30 years of client-side business experience and a formidable network within the pharmaceutical industry.  Prior to joining the Virdis Group John was most recently a Group Director at Pfizer International; and he understands the business pressures which drive our clients’ expectations for high quality executive search.

John has a degree in Zoology and a Master’s degree in Parasitology; he is a Fellow of the Institute of Direct Marketing, a Business Leader in the Marketing Society and a member of the Chartered Institute of Marketing.

His experience includes senior roles in human pharma, animal health and consumer healthcare where he led international change programmes, acquisitions, divestments, a dozen product launches, clinical research programmes and customer facing teams of all sizes.






Virdis is fortunate to collaborate with Lucy Watson-Baker, the founder and President of Kingfisher Talent, based in Boston, Massachusetts. Lucy has worked at the forefront of executive search, recruiting, and talent acquisition, for over fifteen years; and is passionate about the art and science of attracting, engaging, developing, and retaining great talent.

Before founding Kingfisher Talent, Lucy was a partner with one of New England’s largest retained search firms where she co-founded the Life Sciences practice. Her expertise includes recruiting top-tier candidates from high-demand, specialized pools of talent, and executing confidential leadership searches. She is regularly relied upon as a subject matter expert to provide input on human capital challenges and as a sounding board for career advice.

Lucy is a Certified Human Capital Strategist; a member of the Human Capital Institute, the Healthcare Businesswomen’s Association and volunteers as a mentor for the Boston Chapter group mentoring programme.




Tony is an experienced entrepreneurial executive.  He has held various senior leadership positions in Research and Development, becoming World-Wide Head of Clinical Operations for Roche. His product successes include Invirase and Tamiflu which have had significant impact both medically and commercially.

Tony has been Chief Executive Officer of four biotechnology companies, with two of them successfully exited.  He has also been chairman of a number of European and British Biotechnology companies .

During the last few years Tony has specialised in ‘trusted’ advisory roles for CEOs and heads of R&D.  He has a deep belief that people are the key to the fast-moving technology space.  The human, not the machine part, will  be unique selling point for business in the future, where innovation and creativity is key.  Click to go to his suitably-named blog site: The Thought Disruptor.